Open Nav

7 Hills Pharma

  • Upendra Marathi, 7 Hills Pharma

Reach potential investors and development partners

  • Date:Thursday, October 18
  • Time:2:30 PM - 2:45 PM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:7 Hills Pharma is an immuno-oncology company developing drugs drug resistant cancers. In spite of the unprecedented cure rates in rare cancers, the promise of immunotherapy and cell therapy is yet to be realized for solid tumors such as lung, colon, and other cancers. 7 Hills is developing cost-effective technologies that modulate the immune system to increase the effectiveness of immune checkpoint blockade, adoptive cell therapy, and cord blood transplant to treat solid tumors and orphan genetic diseases.
  • Company
  • Company HQ City:Houston, TX
  • Company HQ Country:United States
  • Company HQ State:Texas                            
  • CEO/Top Company Official:Upendra Marathi
  • Year Founded:2014
  • Main Therapeutic Focus:Multiline Global Biopharma
  • Lead Product in Development :7HP-349 (T cell homing)
  • Development Phase of Primary Product:Pre-Clinical
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :2
  • Previous and Current Investors:Angel Investors and Company Co-Founders
  • Size of Last Investment Round:3.750,000
  • Total Amount Raised to Date, In All Rounds:4,000,000
Upendra Marathi
7 Hills Pharma